NCT00471419已完成3 期
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 750
- 试验地点
- 2
- 主要终点
- Corneal staining; dry eye sympton
研究概览
简要总结
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •documented dry eye history
- •ocular symptoms
- •dry eye ocular signs
排除标准
- 未提供
结局指标
主要结局
Corneal staining; dry eye sympton
时间窗: Immediate
次要结局
- Corneal staining; dry eye sympton(Prolonged)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)Autism Spectrum Disorder (ASD)NCT04299464Hoffmann-La Roche104
已完成
2 期
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal LinesLateral Canthal LinesCrow's FeetFacial WrinklesNCT00888914Revance Therapeutics, Inc.60
已完成
2 期
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal LinesLateral Canthal LinesNCT00907387Revance Therapeutics, Inc.72
已完成
2 期
Efficacy Study of Temsirolimus to Treat Head and Neck CancerHead and Neck Squamous Cell CarcinomaNCT01172769Hannover Medical School42
已完成
2 期
Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With InsomniaSleep Initiation and Maintenance DisordersNCT00755508Takeda378